Evidence map›Paper›PMID 39063697›Full record

ArticleMaterials (Basel, Switzerland)2024

Physico-Chemical and Biological Features of Fluorine-Substituted Hydroxyapatite Suspensions.

Carmen Steluta Ciobanu, Daniela Predoi, Simona Liliana Iconaru, Mihai Valentin Predoi, Krzysztof Rokosz, Steinar Raaen, Catalin Constantin Negrila, Nicolas Buton, Liliana Ghegoiu, Monica Luminita Badea

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carmen Steluta CiobanuNational Institute of Materials Physics, Atomistilor Street, No. 405A, 077125 Magurele, Romania.ORCID 0000-0002-6044-4311
Daniela PredoiNational Institute of Materials Physics, Atomistilor Street, No. 405A, 077125 Magurele, Romania.
Simona Liliana IconaruNational Institute of Materials Physics, Atomistilor Street, No. 405A, 077125 Magurele, Romania.ORCID 0000-0002-9139-5903
Mihai Valentin PredoiDepartment of Mechanics, University Politehnica of Bucharest, BN 002, 313 Splaiul Independentei, Sector 6, 060042 Bucharest, Romania.
Krzysztof RokoszFaculty of Electronics and Computer Science, Koszalin University of Technology, Sniadeckich 2, PL 75-453 Koszalin, Poland.ORCID 0000-0002-1040-7213
Steinar RaaenDepartment of Physics, Norwegian University of Science and Technology (NTNU), Realfagbygget E3-124 Høgskoleringen 5, NO 7491 Trondheim, Norway.
Catalin Constantin NegrilaNational Institute of Materials Physics, Atomistilor Street, No. 405A, 077125 Magurele, Romania.
Nicolas ButonHORIBA Jobin Yvon S.A.S., 6-18, Rue du Canal, 91165 Longjumeau CEDEX, France.
Liliana GhegoiuNational Institute of Materials Physics, Atomistilor Street, No. 405A, 077125 Magurele, Romania.
Monica Luminita BadeaFaculty of Horticulture, University of Agronomic Sciences and Veterinary Medicine, 59 Marasti Blvd., 011464 Bucharest, Romania.

Funding

Romanian Ministry of Research, Innovation and Digitalization PC1-PN23080101
6 · The paper itself

Abstract

Infections related to orthopedic/stomatology surgery are widely recognized as a significant health concern. Therefore, the development of new materials with superior biological properties and good stability could represent a valuable alternative to the classical treatments. In this paper, the fluorine-substituted hydroxyapatite (FHAp) suspension, with the chemical formula Ca

Indexed as

antimicrobial propertiesbiocompatibilityfluorine substituted hydroxyapatitestabilitysuspensionsultrasound measurements

Identifiers

PMID39063697
PMCPMC11277939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.